ArticleOphthalmology and therapy2026
Aqueous and Vitreous Ketorolac Levels in Combined Cataract and Pars Plana Vitrectomy with Intracameral Ketorolac 0.3% Versus Topical Ketorolac 0.4.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06539637 (Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionKetorolac is well documented to reduce postoperative inflammation, pain, and the risk of cystoid macular edema (CME) during cataract surgery. The concentration of ketorolac in the vitreous humor following topical administration has been reported to be very low. As there is a lack of evidence on the vitreous levels of ketorolac following intracameral administration, this study aimed to evaluate the concentration of ketorolac in aqueous and vitreous humor samples during combined cataract surgery and pars plana vitrectomy in patients receiving preoperative topical ketorolac 0.4% or intracameral phenylephrine 1.0%/ketorolac 0.3% (OMIDRIA
methodsThis prospective, randomized, controlled study recruited patients undergoing combined cataract surgery and pars plana vitrectomy and randomized in a 1:1 ratio to receive either intracameral phenylephrine 1.0%/ketorolac 0.3% (study arm) or preoperative topical ketorolac 0.4% (control arm). Aqueous samples were collected at the start of cataract surgery in the control arm and at the end of cataract surgery in the study arm. The vitreous samples were taken at the start of vitrectomy in all eyes. The samples were frozen and sent to an independent lab (Emery Pharma, Alameda, CA) for analysis. Ketorolac levels were determined using liquid chromatography-tandem mass spectrometry.
resultsFive eyes of five patients received ketorolac intracamerally, and six eyes of six patients received it topically. The mean aqueous ketorolac concentration was significantly higher in the study eyes than in the control (20,868.2 ± 7342.4 ng/mL versus 635.1 ± 909.6 ng/mL, p < 0.0001). In the vitreous, the mean ketorolac concentration was significantly higher in the study eyes than in the control (2508.8 ± 4477.6 ng/mL versus 3.1 ± 7.7 ng/mL, p = 0.0004).
conclusionsThe intracameral administration of phenylephrine/ketorolac resulted in 33 times higher ketorolac concentration in the aqueous and 809 times higher in the vitreous humor than the topically administered ketorolac during combined cataract surgery and pars plana vitrectomy.
trial registrationClinicalTrials.gov identifier, NCT06539637, date of registration 29 July 2024 (retrospectively registered).
Indexed as
Identifiers
42911532What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.